Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 68001-493

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 20ml (Spl Doxorubicin Carton 1)

This is a product information sheet for the use and dosage of Doxorubicin Hydrochloride Liposome Injection, an intravenous infusion for which the instructions specify the use of 5% Dextrose Injection, USP. The instructions include details on the contents of the injection and its liposomal formulation. The document also includes instructions for storage and proper disposal of the unused medicine. The information sheet is intended for use by healthcare professionals and provides a phone number to contact the manufacturer with questions.*

FDA Label Image

Carton 25ml (Spl Doxorubicin Carton 2)

This is a pharmaceutical product label for Doxorubicin Hydrochloride Liposome Injection, which is a cytotoxic agent for intravenous infusion, stating that it must be diluted prior to use and the liposomal formulation should not be substituted. It also provides the manufacturer details and drug's composition. The recommended dosage is not mentioned, advising to see the prescription information. The text also includes some identification numbers, a warning to discard unused portions, and a notice to store the product at a temperature range between 2°C and 8°C but avoid freezing. The text is not-readable in parts, likely because of errors.*

FDA Label Image

Spl-doxorubicin-figure (Spl Doxorubicin Figure)

This is a representation of a liposome which has been coated with MPEG-DSPE and contains an aqueous core with entrapped doxorubicin HCI. The liposome is made up of a bilayer.*

FDA Label Image

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)

This is a clinical trial description comparing the efficacy of two treatments, Doxorubicin+Bortezomib and Bortezomib, for a certain medical condition. The analysis of the data indicates a statistically significant difference between the treatments, with a p-value < 0.0001 and a hazard ratio of 0.55. The data is presented in a table showing the number of subjects at risk over time. The text also includes some formatting elements such as numbers and symbols.*

FDA Label Image

Label 10ml (Spl Doxorubicin Label 1)

Use 5% Dextrose Injection, USP to dilute Doxorubicin Hydrochloride liposome injection. The usual dosage can be found in the prescribing information. The vial should be kept in its carton until use. This is a cytotoxic agent that must be diluted and is only for intravenous infusion. The liposomal formulation should not be substituted. This must be stored refrigerated and should not be frozen. The 10 mL vial is manufactured by Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories. A lot number and expiration date are provided.*

FDA Label Image

Label (Spl Doxorubicin Label 2)

This text provides instructions and important details about Doxorubicin Hydrochloride Liposome Injection, a cytotoxic agent that must be diluted before intravenous infusion. It emphasizes using 5% Dextrose Injection, USP for dilution, and cautions not to substitute for other formulations. The usual dosage is not provided, and the user is directed to see the prescribing information. The vial must be stored in a refrigerator and should not be frozen. The text also indicates the manufacturer and information about the lot and expiration date.*

FDA Label Image

Spl-doxorubicin-structure (Spl Doxorubicin Structure)

FDA Label Image

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)

FDA Label Image

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)

The provided text is a structural formula for an unknown compound with the abbreviation HSPC. The formula shows a chain of atoms consisting of carbon, nitrogen, oxygen, and hydrogen atoms. The abbreviation "mn" is given with a value of either 14 or 16, which may refer to the molar mass or atomic mass of the compound.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.